MedTrace

Banner image with text: 'Stay informed with the latest IP news' and the following words listed: Insights, Interviews, Webinars.

MedTrace receives $30 million investment fuelling US expansion and new business area

By AWA | Posted on May 13, 2021

AWA’s client MedTrace Pharma A/S has received nearly $30 million from Swiss-based Swisscanto Invest and Danish investors ATP and BankInvest. MedTrace has developed a fully automated technology that makes radioactive water clinically available to patients in need of diagnostic heart imaging. Radioactive water (15O-water), currently used on occasion for various scans, will now be produced...

Tags: investment, MedTrace, patents, technology

Recent contributors

Ylva Strandberg, Counsel and AU and NZ Patent Attorney, Stockholm, Sweden

Ylva Strandberg

Counsel, AU and NZ Patent Attorney

Hongyue Li, Senior Associate and China Patent Attorney, Beijing, China

Hongyue Li

Senior Associate, China Patent Attorney

Isa Böttiger, Associate and Attorney at Law, Stockholm, Sweden

Isa Böttiger

Associate, Attorney at Law

Ylva Wikmark, Counsel and European Patent Attorney, Stockholm, Sweden

Ylva Wikmark

Counsel, European Patent Attorney

Ashley Zhao, Partner and Attorney at Law, Beijing, China

Ashley Zhao

Partner, Attorney at Law, Business Area Manager

Alexandre Theodorou, Partner and European Patent Attorney, Brussels, Belgium

Alexandre Theodorou

Partner, European Patent Attorney